首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Cancer Immunology Research

Cancer Immunology Research杂志,由American Association for Cancer Research Inc.出版,于2013年创刊,12 issues/year,出版语言English,ISSN:2326-6066,E-ISSN:2326-6074。

投稿咨询
Cancer Immunology Research
Cancer Immunology Research
Cancer Immunology Research
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
7.9
CiteScore
12.6
期刊收录
SCI、SCIE

Cancer Immunology Research(中文译名:《癌症免疫学研究》),ISSN:2326-6066,EISSN:2326-6074,是American Association for Cancer Research Inc.出版的国际性学术期刊,创刊于2013年,以12 issues/year形式稳定发行,2026年总发文量约131篇。该刊采用非OA开放访问,学科归属为ONCOLOGY - IMMUNOLOGY。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达7.9,2025年期刊CiteScore为12.6,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Cancer Immunology Research长期聚焦医学、肿瘤学及相关产业的技术应用前沿,在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、GERMANY (FED REP GER)、England、Japan、Netherlands、France等为核心发文国家与地区;HARVARD UNIVERSITYDANA-FARBER CANCER INSTITUTE、UNIVERSITY OF CALIFORNIA SYSTEM、UNIVERSITY OF TEXAS SYSTEM、MEMORIAL SLOAN KETTERING CANCER CENTER、UNIVERSITY OF PENNSYLVANIA、JOHNS HOPKINS UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学 IMMUNOLOGY 免疫学
2区 2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
IMMUNOLOGY 免疫学 ONCOLOGY 肿瘤学
2区 2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
IMMUNOLOGY 免疫学 ONCOLOGY 肿瘤学
1区 2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 22 / 183

88.3

学科:ONCOLOGY SCIE Q1 45 / 333

86.6

学科:IMMUNOLOGY SCIE Q1 16 / 183

91.53

学科:ONCOLOGY SCIE Q1 33 / 333

90.24

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 20 / 181

89.2

学科:ONCOLOGY SCIE Q1 35 / 322

89.3

学科:IMMUNOLOGY SCIE Q1 15 / 181

91.99

学科:ONCOLOGY SCIE Q1 32 / 322

90.22


中国学者近期发文

1
Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppressio

Author:Yang, Fuhan; Zhang, Wentao; Wang, Ruiliang; Mao, Shiyu; Liu, Yong-Qiang; Jiang, Yan-Shan; Yu, Yao; Wu, Pengfei; Yu, Yang; Chen, Hao-Tian; Guo, Ya-Dong; Ma, Hui-Hui; Wang, Wen; Yao, Xudong; Jia, Xin-Ming

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue 3, pp. 387-398. DOI: 10.1158/2326-6066.CIR-25-0873

2
Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ-IRF1-SREBF2 Axi

Author:Xu, Liping; Zhang, Xiaomin; Lai, Xiaowei; Chen, Hongyuan; Liao, Shuangye; Chang, Mingzeng; Wu, Xiaoqing; Rui, Wen; Yang, Juan; Wang, Danyang; Gao, Chengqi; Fang, Ziqian; Zhang, Jianeng; Li, Wende; Li, Bo; Xia, Xiaojun; Zhou, Penghui

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue 3, pp. 478-490. DOI: 10.1158/2326-6066.CIR-25-0242

3
Single-cell spatial immune architectures shape ctDNA release and prognosis in luminal breast cance

Author:Xu, Hengyi; Pu, Pengming; Liu, Jiaqi

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue , pp. -. DOI: 10.1158/2326-6074.IO2026-A037

4
Identification and validation of an explainable predictive model for early diagnosis of non-small cell lung cancer metastasis: A peripheral immune score based on integrative machine learnin

Author:Tian, Jianhui; Xu, Fan; Luo, Bin; Chen, Zhenyang; Yao, Yuan; Liu, Youjun; Yang, Xiaoyu; Yao, Jiangliang; Yao, Wang; Lu, Xinyi; Bao, Yuchen; Zhou, Yiyang; Wu, Jianchun; Li, Minghua; Shi, Wenfei; Cui, Yajing; Wang, Yanhong; Wu, Yunxia; Yang, Yun; Li, Yan

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue , pp. -. DOI: 10.1158/2326-6074.IO2026-A035

5
A retrospective clinical study on the 5-year and 10-year survival rates of postoperative malignant tumor patients treated with DC-CI

Author:Gao, Daiqing; Sun, Weihong; Zhu, Danni; Li, Changyou; Wei, Xiaofang; Xie, Shishun

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue , pp. -. DOI: 10.1158/2326-6074.IO2026-A017

6
Large-scale single-cell and spatial multi-omics elucidate the mechanism by which mitochondrial copper metabolism biomarkers promote immune evasion in breast cance

Author:Chu, Bowen; Tong, Xin; Tang, Xinhao; Wang, Xiaoya; Tian, Xinyu; Zhang, Rui; Jiang, Yijun; Yan, Shuai; Hao, Shuai

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue , pp. -. DOI: 10.1158/2326-6074.IO2026-A038

7
Phase 1 Monotherapy and Combination Data for HCB101, a Novel SIRPα-Fc Innate Checkpoint Fusion Protei

Author:Ning, Fangling; Iannotti, Nicholas O.; Cheng, Wei-Hong; Lin, Chia-Chi; Ma, Ji; Mu-Hsin. Chang, Peter; Wang, Ying; Edenfield, William Jeffery.; Li, Wenyu; Zhang, Tian; Zhang, Jian; Chen, Guohua; Mo, Fei; Yu, Langtian Abigail.; Luk, Alvin

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue , pp. -. DOI: 10.1158/2326-6074.IO2026-B076

8
Association of different TP53 mutation subtypes with the efficacy of first-line immunotherapy in locally advanced and metastatic lung squamous cell carcinom

Author:Liang, Yingyun; Yang, Ying; Lu, Shun

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue , pp. -. DOI: 10.1158/2326-6074.IO2026-B064

9
FAM135B Deficiency Inhibits Cytotoxic T-cell Activity in Triple-Negative Breast Cancer by Blocking the IFI16-Dependent STING Pathwa

Author:Lin, Wanmei; Li, Junze; Wu, Jun; Huang, Bin; Liang, Junguang; Zhang, Yuan; Zhao, Liang; Yao, Guangyu

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue 2, pp. 335-349. DOI: 10.1158/2326-6066.CIR-25-0310

10
The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunit

Author:Chantzoura, Eleni; Altman-Sharoni, Efrat; Michelet, Xavier; Popis, Martyna C.; Niedzielska, Magdalena; Joshi, Bishnu; Masakayan, Reed; Rubi-Sans, Gerard; Addis, Stephen; Keith, Justin G.; Krishnan, Shanmugarajan; Choi, Jin San; Sanders, Stephanie; Sebastian-Yague, Alvaro; Boi, Shannon K.; Pinzan-Rossi, Moira; Antonopoulos, Georgios; Ibbett, Paul; Wright, Deborah E.; Le Tonqueze, Olivier; Kushner, Nick; Pathak, Chinar; Soh, Kah Teong; Chalmers, Amy L.; Smith, Rachel; Venkatraman, Vignesh; Farahi, Sara; Pravin, John; Iyer, Priyadarshini; Briend, Emmanuel; Ignatovich, Olga; Purbhoo, Marco A.; Curiel, Tyler J.; Exley, Mark A.; Stein, Robert B.; Kim, Enoch; Buell, Jennifer S.; van Dijk, Marc A.; Chand, Dhan

Journal: CANCER IMMUNOLOGY RESEARCH. 2026; Vol. 14, Issue 2, pp. 243-260. DOI: 10.1158/2326-6066.CIR-25-0349


在线咨询

Cancer Immunology Research

国际简称:CANCER IMMUNOL RES参考译名:癌症免疫学研究

年发文量:131 CiteScore:12.6 是否预警:否 Gold OA文章占比:32.68% 研究类文章占比:94.66%

杂志社联系方式:615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404

Cancer Immunology Research